| View |
|
DRP-10097-01
|
Citicoline (as sodium)
|
Calyxin
|
250 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Aju Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
29 September 2021
|
21 October 2025
|
| View |
|
DRP-12392-04
|
Cefalexin (as monohydrate)
|
Rapelex
|
100 mg/mL
|
Powder for Suspension for Oral Drops
|
Antibacterial (First Generation Cephalosporins)
|
Azarias Pharmaceutical Laboratories Inc..
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|
| View |
|
DRP-7065-01
|
Sodium alginate + Sodium bicarbonate + Calcium carbonate
|
Kremil-S Cool Relief
|
500 mg/213 mg/325 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Genuone Sciences, Inc.
|
Korea
|
CLIDP Conversion
|
07 July 2022
|
23 February 2027
|
| View |
|
DRP-2449-01
|
Ofloxacin
|
None
|
3 mg/mL (0.3% w/v)
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Ashford Pharmaceutical Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
22 August 2022
|
14 May 2025
|
| View |
|
DRP-9812-02
|
Polyethylene Glycol 3350 (PEG) + Mineral Salts
|
Sporogut
|
(See formulation)
|
Powder for Oral Solution (Lemon)
|
Osmotically Acting Laxative
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
20 June 2022
|
14 June 2026
|
| View |
|
DRP-276-07
|
Ciprofloxacin (as hydrochloride)
|
Floxazin
|
500mg
|
Tablet
|
-
|
Flamingo Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
20 October 2022
|
30 September 2027
|
| View |
|
DRP-11848-01
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Acantha Plus
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
07 July 2022
|
10 May 2027
|
| View |
|
DRP-10929-05
|
Norepinephrine (As Bitartrate)
|
Hypomed
|
1mg/mL (4mg/4mL)
|
Solution for Injection (IV)
|
Adrenergic/Dopaminergic Agent
|
Mackur Laboratories Limited
|
India
|
Automatic Renewal
|
25 May 2022
|
31 January 2027
|
| View |
|
DRP-7357-04
|
Cefixime (as trihydrate)
|
Fixhil 400
|
400 mg
|
Dispersible Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd
|
India
|
Renewal
|
18 March 2024
|
26 February 2029
|
| View |
|
DRP-2645-02
|
Co-Amoxiclav
|
Xyveemox
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor combination)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
CLIDP Conversion
|
24 August 2021
|
18 June 2026
|
| View |
|
DRP-10091-01
|
Norepinephrine (as bitartrate)
|
Sephrine
|
1 mg/mL (4 mg/4 mL)
|
Solution for I.V. Injection
|
Adrenergic And Dopaminergic Agent
|
Aju Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
05 November 2021
|
21 October 2025
|
| View |
|
DRP-9703-01
|
Ascorbic Acid
|
Korbic Kids
|
100 mg
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
29 April 2022
|
06 May 2026
|
| View |
|
DRP-3109-09
|
Atorvastatin (as Calcium)
|
Klotor-S
|
40 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
05 April 2024
|
12 July 2029
|
| View |
|
DRP-7127-02
|
Sitagliptin (as phosphate monohydrate)
|
None
|
25 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
07 February 2022
|
20 April 2026
|
| View |
|
DRP-10476-04
|
Telmisartan
|
Teldra
|
80 mg
|
Tablet
|
-
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
27 June 2022
|
30 September 2026
|
| View |
|
DRP-10476-03
|
Telmisartan
|
MEVO 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
21 March 2022
|
30 September 2026
|
| View |
|
DRP-906-06
|
Losartan Potassium
|
Jysartan 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin-2-Receptor Blockers (ARBs)
|
Zim Laboratories Limited
|
India
|
Renewal
|
21 March 2023
|
22 April 2028
|
| View |
|
DRP-12407-04
|
Cefalexin (as monohydrate)
|
Rapelex
|
125 mg/5 mL
|
Powder for Suspension
|
Antibacterial (First Generation Cephalosporin)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
03 October 2022
|
21 July 2027
|
| View |
|
DRP-7356-02
|
Cefixime (as trihydrate)
|
Rexmecef 200
|
200 mg
|
Film Coated Tablet
|
Antibacterial (Cephalosporin)
|
Swiss Pharma Pvt. Ltd.
|
India
|
Renewal
|
16 May 2024
|
21 February 2029
|
| View |
|
DRP-10801-04
|
Sodium bicarbonate
|
Sodiqo
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V. Infusion)
|
Electrolyte Replenisher/Systemic Alkalinising Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
11 April 2022
|
21 December 2026
|